AMRX R&D Expenses
Amneal Pharmaceuticals Inc Class A · R&D Expenses
AMRX R&D Expenses
Latest reported$41.10Mperiod ending
AMRX Quarterly R&D Expenses ($43.51M → $41.10M)
Quarterly R&D Expenses
High-resolution chart · PNG
AMRX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 41,104,000 | |
| 38,383,000 | |
| 34,819,000 | |
| 63,352,000 | |
| 49,981,000 | |
| 41,807,000 | |
| 56,117,000 | |
| 61,097,000 | |
| 37,096,000 | |
| 39,298,000 | |
| 46,564,000 | |
| 42,261,000 | |
| 38,619,000 | |
| 40,334,000 | |
| 43,269,000 | |
| 51,646,000 | |
| 51,569,000 | |
| 53,562,000 | |
| 53,016,000 | |
| 50,554,000 | |
| 54,229,000 | |
| 51,764,000 | |
| 57,161,000 | |
| 46,653,000 | |
| 49,122,000 | |
| 37,649,000 | |
| 53,025,000 | |
| 40,711,000 | |
| 50,527,000 | |
| 58,024,000 | |
| 60,534,000 | |
| 47,400,000 | |
| 54,382,000 | |
| 48,785,000 | |
| 46,226,000 | |
| 48,016,000 | |
| 52,110,000 | |
| 39,419,000 | |
| 43,513,000 |